Lumosa Therapeutics is delighted to announce the appointment of Dr. Chang-Hai Tsai as the new Chairman of its Board succeeding Dr. Rong-jin Lin. Dr. Tsai has been devoting his efforts in academic and research fields for over 30 years, accumulating extensive knowledge and expertise in biomedical area. He is currently one of the National Policy Advisors to the President, serves as the Chairman of the Board of China Medical University Hospital & China Medical University and is also the founding chairman of Asia University. Lumosa would like to convey its appreciation to Dr. Lin. His leadership, talent and experience have been a great asset to the company in his time as Chairman.